Polymorphisms in the F8 Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies during the Treatment of Hemophilia A: A Computational Assessment

CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice

(2012) K. N. Steinitz et al.   BLOOD

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis

(2012) S. C. Gouw et al.   BLOOD

T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site

(2011) E. A. JAMES et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Improvements in factor concentrates

(2010) David Lillicrap   CURRENT OPINION IN HEMATOLOGY

MHC Class II epitope predictive algorithms

(2010) Morten Nielsen et al.   IMMUNOLOGY

Factor VIII Inhibitors: Risk Factors and Methods for Prevention and Immune Modulation

(2009) Ai Hong Zhang et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Peptide-MHC Class II Complex Stability Governs CD4 T Cell Clonal Selection

(2009) C. K. Baumgartner et al.   JOURNAL OF IMMUNOLOGY

Inhibitors of Factor VIII in Black Patients with Hemophilia

(2009) Kevin R. Viel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A

(2008) S. Lacroix-Desmazes et al.   BLOOD

Inhibitor Development

(2008) J. ASTERMARK et al.   HAEMOPHILIA

Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan

(2008) Morten Nielsen et al.   PLoS Computational Biology

A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach

(2008) Peng Wang et al.   PLoS Computational Biology